Effects of high dose angiotensin II receptor blocker - comparison of Valsartan and Candesartan

被引：0
|
作者：
Ohishi, Mitsuru [1 ]
Ito, Norihisa [1 ]
Takagi, Takashi [1 ]
Terai, Minako [1 ]
Tatara, Yuji [1 ]
Shiota, Atsushi [1 ]
Hayashi, Norihiro [1 ]
Katsuya, Tomohiro [1 ]
Rakugi, Hiromi [1 ]
Ogihara, Toshio [1 ]
机构：
[1] Osaka Univ, Sch Med, Suita, Osaka 565, Japan
来源：
JOURNAL OF HYPERTENSION | 2006年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：364 / 364
页数：1
相关论文
共 50 条
  • [41] Cancer Risk of Angiotensin II Receptor Blocker Valsartan: A Population-based Study
    Chan, Tak Hon
    Tsoi, Man Fung
    Yung Cheung, Bernard Man
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (04) : 577 - 582
  • [42] Effects of the angiotensin AT1 receptor blocker candesartan on myocardial ischemic/reperfusion injury
    Shimizu, M
    Sjöquist, PO
    Wang, QD
    Rydén, L
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1999, 10 : S137 - S142
  • [43] Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan
    Miura, Shin-ichiro
    Okabe, Atsutoshi
    Matsuo, Yoshino
    Karnik, Sadashiva S.
    Saku, Keijiro
    HYPERTENSION RESEARCH, 2013, 36 (02) : 134 - 139
  • [44] Beneficial effects of candesartan, an angiotensin II type I receptor blocker, on β-cell function and morphology in db/db mice
    Shao, Jiaqing
    Iwashita, Noseki
    Ikeda, Fuki
    Ogihara, Takeshi
    Uchida, Toyoyoshi
    Shimizu, Tomoaki
    Uchino, Hiroshi
    Hirose, Takahisa
    Kawamori, Ryuzo
    Watada, Hirotaka
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 344 (04) : 1224 - 1233
  • [45] Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan
    Shin-ichiro Miura
    Atsutoshi Okabe
    Yoshino Matsuo
    Sadashiva S Karnik
    Keijiro Saku
    Hypertension Research, 2013, 36 : 134 - 139
  • [46] Candesartan cilexetil: a new, long acting, effective angiotensin II type 1 receptor blocker
    Sever, P
    JOURNAL OF HUMAN HYPERTENSION, 1997, 11 : S91 - S95
  • [47] The Angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer
    Okazaki, Mitsuyoshi
    Fushida, Sachio
    Harada, Shinichi
    Tsukada, Tomoya
    Kinoshita, Jun
    Oyama, Katsunobu
    Tajima, Hidehiro
    Ninomiya, Itasu
    Fujimura, Takashi
    Ohta, Tetsuo
    CANCER LETTERS, 2014, 355 (01) : 46 - 53
  • [48] Renoprotective effects of angiotensin II receptor blocker, candesartan cilexetil, in patients with stage 4–5 chronic kidney disease
    Yoshifuru Tamura
    Masahiro Kosuga
    Masahiro Yamashita
    Satoru Tomioka
    Michiko Sasaki
    Tomoyuki Hikita
    Hideaki Nakajima
    Kenichiro Kojima
    Shunya Uchida
    Clinical and Experimental Nephrology, 2008, 12 : 256 - 263
  • [49] The impact of a dose of the angiotensin receptor blocker valsartan on post-myocardial infarction ventricular remodelling
    Park, Kyungil
    Kim, Young-Dae
    Kim, Ki-Sik
    Lee, Su-Hoon
    Park, Tae-Ho
    Lee, Sang-Gon
    Kim, Byung-Soo
    Hur, Seung-Ho
    Yang, Tae-Hyun
    Oh, Joo-Hyun
    Hong, Taek-Jong
    Park, Jong-Sun
    Hwang, Jin-Yong
    Jeong, Byungcheon
    Bae, Woo-Hyung
    ESC HEART FAILURE, 2018, 5 (02): : 354 - 363
  • [50] Regression of Atherosclerosis in Apolipoprotein E-Deficient Mice is Feasible Using High-Dose Angiotensin Receptor Blocker, Candesartan
    Hayashi, Kaori
    Sasamura, Hiroyuki
    Azegami, Tatsuhiko
    Itoh, Hiroshi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (08) : 736 - 746
12345